ON-bipolar cell gene expression during retinal degeneration: Implications for optogenetic visual restoration

0301 basic medicine Retinal Bipolar Cells Genetic Vectors Retinal Degeneration Mice, Transgenic Inherited retinal degeneration Dependovirus Flow Cytometry Real-Time Polymerase Chain Reaction Immunohistochemistry Spermidine Synthase Article 3. Good health Optogenetics Mice 03 medical and health sciences Gene Expression Regulation Contactin 1 Animals Annexin A7 Female Gene expression Bipolar cell Sulfatases
DOI: 10.1016/j.exer.2021.108553 Publication Date: 2021-03-31T19:43:16Z
ABSTRACT
Retinal bipolar cells survive even in the later stages of inherited retinal degenerations (IRDs) and so are attractive targets for optogenetic approaches to vision restoration. However, it is not known what extent remodelling that these undergo during degeneration affects their function. Specifically, unclear if they free from metabolic stress, receptive adeno-associated viral vectors, suitable opsin-based tools able propagate signals by releasing neurotransmitter. Fluorescence activated cell sorting (FACS) was performed isolate labelled dissociated retinae litter-mates with or without IRD mutation Pde6brd1/rd1 selectively expressing an enhanced yellow fluorescent protein (EYFP) as a marker ON-bipolar cells. Subsequent mRNA extraction allowed Illumina® microarray comparison gene expression degenerate those wild type retinae. Changes four candidate genes were further investigated at level using immunohistochemistry over course degeneration. A total sixty differentially expressed transcripts reached statistical significance: did include any directly associated native primary signalling, nor changes consistent stress. Four significantly altered (Srm2, Slf2, Anxa7 & Cntn1), implicated synaptic remodelling, neurotransmitter release vector entry had immunohistochemical staining colocalising markers varying Our findings suggest relatively few context degeneration: despite likely remain viable In addition, several where seen could provide basis investigations enhance efficacy therapies.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (68)
CITATIONS (20)